Australia TGA ARTG recordSuture, polypropylene monofilament
Australia TGA ARTG Registered Device · Pacific Dental Specialties Pty Ltd · Osteogenics Biomedical Inc · Class IIa · Started July 28, 2023
Good Name: Pacific Dental Specialties Pty Ltd - Suture, polypropylene monofilament
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- July 28, 2023
- Effective Date
- July 28, 2023
- Country
- United States of America
- Address
- 4620 71st Street Building 78-79, Lubbock, TX, 79424
Cytoplast PTFE Suture is indicated for use in most types of soft tissue approximation and/or ligation, including dental surgeries. Cytoplast PTFE Suture is designed for short term use and must be removed. The device is not indicated for use in cardiovascular surgery, ophthalmic surgery, microsurgery and central/peripheral neural tissue surgery.
Access comprehensive regulatory information for Suture, polypropylene monofilament in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Pacific Dental Specialties Pty Ltd, manufactured by Osteogenics Biomedical Inc in United States of America. The device registration started on July 28, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.